Literature DB >> 26054501

Vitamin E: Curse or Benefit in Alzheimer's Disease? A Systematic Investigation of the Impact of α-, γ- and δ-Tocopherol on Aß Generation and Degradation in Neuroblastoma Cells.

M O W Grimm1, C P Stahlmann, J Mett, V J Haupenthal, V C Zimmer, J Lehmann, B Hundsdörfer, K Endres, H S Grimm, T Hartmann.   

Abstract

OBJECTIVES: The E vitamins are a class of lipophilic compounds including tocopherols, which have high antioxidative properties. Because of the elevated lipid peroxidation and increased reactive oxidative species in Alzheimer's disease (AD) many attempts have been made to slow down the progression of AD by utilizing the antioxidative action of vitamin E. Beside the mixed results of these studies nothing is known about the impact of vitamin E on the mechanisms leading to amyloid-β production and degradation being responsible for the plaque formation, one of the characteristic pathological hallmarks in AD. Here we systematically investigate the influence of different tocopherols on Aβ production and degradation in neuronal cell lines. MEASUREMENTS: Beside amyloid-β level the mechanisms leading to Aβ production and degradation are examined.
RESULTS: Surprisingly, all tocopherols have shown to increase Aβ level by enhancing the Aβ production and decreasing the Aβ degradation. Aβ production is enhanced by an elevated activity of the involved enzymes, the β- and γ-secretase. These secretases are not directly affected, but tocopherols increase their protein level and expression. We could identify significant differences between the single tocopherols; whereas α-tocopherol had only minor effects on Aβ production, δ-tocopherol showed the highest potency to increase Aβ generation. Beside Aβ production, Aβ clearance was decreased by affecting IDE, one of the major Aβ degrading enzymes.
CONCLUSIONS: Our results suggest that beside the beneficial antioxidative effects of vitamin E, tocopherol has in respect to AD also a potency to increase the amyloid-β level, which differ for the analysed tocopherols. We therefore recommend that further studies are needed to clarify the potential role of these various vitamin E species in respect to AD and to identify the form which comprises an antioxidative property without having an amyloidogenic potential.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26054501     DOI: 10.1007/s12603-015-0506-z

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


  70 in total

1.  Total inactivation of gamma-secretase activity in presenilin-deficient embryonic stem cells.

Authors:  A Herreman; L Serneels; W Annaert; D Collen; L Schoonjans; B De Strooper
Journal:  Nat Cell Biol       Date:  2000-07       Impact factor: 28.824

Review 2.  Vitamin E: antioxidant activity, biokinetics, and bioavailability.

Authors:  G W Burton; M G Traber
Journal:  Annu Rev Nutr       Date:  1990       Impact factor: 11.848

Review 3.  The role of antioxidants and pro-oxidants in colon cancer.

Authors:  William L Stone; Koyamangalath Krishnan; Sharon E Campbell; Victoria E Palau
Journal:  World J Gastrointest Oncol       Date:  2014-03-15

4.  Beta-secretase processing in the trans-Golgi network preferentially generates truncated amyloid species that accumulate in Alzheimer's disease brain.

Authors:  Jason T Huse; Kangning Liu; Donald S Pijak; Dan Carlin; Virginia M-Y Lee; Robert W Doms
Journal:  J Biol Chem       Date:  2002-02-14       Impact factor: 5.157

5.  Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.

Authors:  Francesca Mangialasche; Alina Solomon; Ingemar Kåreholt; Babak Hooshmand; Roberta Cecchetti; Laura Fratiglioni; Hilkka Soininen; Tiina Laatikainen; Patrizia Mecocci; Miia Kivipelto
Journal:  Exp Gerontol       Date:  2013-10-07       Impact factor: 4.032

6.  From brain to food: analysis of phosphatidylcholins, lyso-phosphatidylcholins and phosphatidylcholin-plasmalogens derivates in Alzheimer's disease human post mortem brains and mice model via mass spectrometry.

Authors:  Marcus O W Grimm; Sven Grösgen; Matthias Riemenschneider; Heikki Tanila; Heike S Grimm; Tobias Hartmann
Journal:  J Chromatogr A       Date:  2011-07-30       Impact factor: 4.759

7.  Docosahexaenoic acid reduces amyloid beta production via multiple pleiotropic mechanisms.

Authors:  Marcus O W Grimm; Johanna Kuchenbecker; Sven Grösgen; Verena K Burg; Benjamin Hundsdörfer; Tatjana L Rothhaar; Petra Friess; Martijn C de Wilde; Laus M Broersen; Botond Penke; Mária Péter; László Vígh; Heike S Grimm; Tobias Hartmann
Journal:  J Biol Chem       Date:  2011-02-15       Impact factor: 5.157

Review 8.  Gamma-tocopherol--an underestimated vitamin?

Authors:  Karl-Heinz Wagner; Afaf Kamal-Eldin; Ibrahim Elmadfa
Journal:  Ann Nutr Metab       Date:  2004-07-12       Impact factor: 3.374

Review 9.  Current status of antioxidant therapy for Alzheimer's Disease.

Authors:  S S Pitchumoni; P M Doraiswamy
Journal:  J Am Geriatr Soc       Date:  1998-12       Impact factor: 5.562

Review 10.  Neprilysin and amyloid beta peptide degradation.

Authors:  Louis B Hersh; David W Rodgers
Journal:  Curr Alzheimer Res       Date:  2008-04       Impact factor: 3.498

View more
  13 in total

Review 1.  Systemic Oxidative Stress: A key Point in Neurodegeneration - A Review.

Authors:  E E Martínez Leo; M R Segura Campos
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

2.  Enhanced defense against ferroptosis ameliorates cognitive impairment and reduces neurodegeneration in 5xFAD mice.

Authors:  Liuji Chen; Nawab John Dar; Ren Na; Kirsten Danae McLane; Kwangsun Yoo; Xianlin Han; Qitao Ran
Journal:  Free Radic Biol Med       Date:  2022-01-06       Impact factor: 7.376

3.  APP intracellular domain derived from amyloidogenic β- and γ-secretase cleavage regulates neprilysin expression.

Authors:  Marcus O W Grimm; Janine Mett; Christoph P Stahlmann; Sven Grösgen; Viola J Haupenthal; Tamara Blümel; Benjamin Hundsdörfer; Valerie C Zimmer; Nadine T Mylonas; Heikki Tanila; Ulrike Müller; Heike S Grimm; Tobias Hartmann
Journal:  Front Aging Neurosci       Date:  2015-05-19       Impact factor: 5.750

Review 4.  Neuroprotection and antioxidants.

Authors:  Maria Lalkovičová; Viera Danielisová
Journal:  Neural Regen Res       Date:  2016-06       Impact factor: 5.135

Review 5.  Vitamin E, Turmeric and Saffron in Treatment of Alzheimer's Disease.

Authors:  Nur Adalier; Heath Parker
Journal:  Antioxidants (Basel)       Date:  2016-10-25

Review 6.  The Impact of Vitamin E and Other Fat-Soluble Vitamins on Alzheimer´s Disease.

Authors:  Marcus O W Grimm; Janine Mett; Tobias Hartmann
Journal:  Int J Mol Sci       Date:  2016-10-26       Impact factor: 5.923

7.  Tocotrienol Affects Oxidative Stress, Cholesterol Homeostasis and the Amyloidogenic Pathway in Neuroblastoma Cells: Consequences for Alzheimer's Disease.

Authors:  Marcus O W Grimm; Liesa Regner; Janine Mett; Christoph P Stahlmann; Pascal Schorr; Christopher Nelke; Olga Streidenberger; Hannah Stoetzel; Jakob Winkler; Shatha R Zaidan; Andrea Thiel; Kristina Endres; Heike S Grimm; Dietrich A Volmer; Tobias Hartmann
Journal:  Int J Mol Sci       Date:  2016-10-29       Impact factor: 5.923

8.  Vitamin D and Its Analogues Decrease Amyloid-β (Aβ) Formation and Increase Aβ-Degradation.

Authors:  Marcus O W Grimm; Andrea Thiel; Anna A Lauer; Jakob Winkler; Johannes Lehmann; Liesa Regner; Christopher Nelke; Daniel Janitschke; Céline Benoist; Olga Streidenberger; Hannah Stötzel; Kristina Endres; Christian Herr; Christoph Beisswenger; Heike S Grimm; Robert Bals; Frank Lammert; Tobias Hartmann
Journal:  Int J Mol Sci       Date:  2017-12-19       Impact factor: 5.923

Review 9.  APP Function and Lipids: A Bidirectional Link.

Authors:  Marcus O W Grimm; Janine Mett; Heike S Grimm; Tobias Hartmann
Journal:  Front Mol Neurosci       Date:  2017-03-10       Impact factor: 5.639

Review 10.  Nutrition and AGE-ing: Focusing on Alzheimer's Disease.

Authors:  Giulia Abate; Mariagrazia Marziano; Wiramon Rungratanawanich; Maurizio Memo; Daniela Uberti
Journal:  Oxid Med Cell Longev       Date:  2017-01-12       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.